Table 3.
Preferences for respirator type under hypothetical risk scenarios (unadjusted)
| Current EHFR users (N = 280) | Current N95-FFR users (N = 606) | Current PAPR users (N = 266) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Preferred respirator |
Preferred respirator |
Preferred respirator |
|||||||
| Scenario | EHFR | N95-FFR (%) | PAPR | EHFR | N95-FFR (%) | PAPR | EHFR | N95-FFR (%) | PAPR |
| Rule out TB (usual circumstance) | |||||||||
| 56 | 37 | 6 | 11 | 78 | 12 | 10 | 40 | 50 | |
| Active TB | |||||||||
| 69 | 15 | 16 | 29 | 44 | 28 | 16 | 18 | 66 | |
| Pandemic H1N1 or SARS | |||||||||
| 61 | 18 | 21 | 23 | 46 | 31 | 18 | 21 | 62 | |
EHFR, elastomeric half-face respirator; N95-FFR, N95 filtering facepiece respirator; PAPR, powered air-purifying respirator; TB, tuberculosis; H1N1, H1N1 influenza; SARS, severe acute respiratory syndrome.